PROGNOSTIC IMPLICATION OF IPSS AND IPSS-R FOR PATIENTS WITH LOWER-RISK MDS TREATED WITH HYPOMETHYLATING AGENTS

被引：0
|
作者：
Moon, J. H. [1 ]
Sohn, S. K. [1 ]
Sook, A. Jae [2 ]
Kim, H. J. [2 ]
Song, M. K. [3 ]
Chung, J. S. [3 ]
Lim, S. N. [4 ]
Bae, S. H. [5 ]
机构：
[1] Kyungpook Natl Univ Hosp, Deagu, South Korea
[2] Cheonnam Natl Univ, Hwasun Hosp, Cheonnam, South Korea
[3] Busan Natl Univ Hosp, Pusan, South Korea
[4] Inje Univ, Paik Hosp, Pusan, South Korea
[5] Daegu Catholic Univ, Med Ctr, Deagu, South Korea
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P919
引用
收藏
页码：345 / 346
页数：2
相关论文
共 50 条
  • [31] A Retrospective Validation Study Comparing the IPSS-M and IPSS-R Risk Stratification Scores in Primary and Secondary Myelodysplastic Syndrome (MDS)
    Sabile, Jean M. G.
    Kaempf, Andy
    Tomic, Kaitlyn
    Manu, Gurusidda
    Swords, Ronan T.
    Migdady, Yazan
    BLOOD, 2022, 140 : 4088 - 4089
  • [32] INTERMEDIATE RISK KARYOTYPE BY IPSS-R CAN BE SEPARATED INTO 5 PROGNOSTICALLY DISTINCT SUBGROUPS IN MDS PATIENTS
    Nachtkamp, K.
    Flatten, V.
    Hildebrandt, B.
    Kasprzak, A.
    Schulz, F.
    Strupp, C.
    Haase, D.
    Ganster, C.
    Shirneshan, K.
    Rittscher, K.
    Goetze, K.
    Hofmann, W. -K.
    Platzbecker, U.
    Pfeilstoecker, M.
    Valent, P.
    Blum, S.
    Luebbert, M.
    Parmentier, S.
    Beier, F.
    Sockel, K.
    Nusch, A.
    Gattermann, N.
    Germing, U.
    LEUKEMIA RESEARCH, 2023, 128
  • [33] The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Mukherjee, Sudipto
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Keng, Michael K.
    Seastone, David J.
    Hobson, Sean
    Advani, Anjali S.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2013, 122 (21)
  • [34] Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study
    Lee, Je-Hwan
    Kim, Yoo-Jin
    Sohn, Sang Kyun
    Yoon, Sung-Soo
    Kim, Hawk
    Cheong, June-Won
    Lee, Won-Sik
    Lee, Gyeong-Won
    Lim, Sung-Nam
    Kim, Min Kyoung
    Lee, Ho Sup
    Kim, Hyeoung-Joon
    LEUKEMIA RESEARCH, 2017, 60 : 135 - 144
  • [35] Are IPSS-R and IPSS Cytogenetic Risk Stratification Informative At the Time of Allogeneic Hematopoietic Cell Transplantation?
    Sachs, Zohar
    Dollan, Michelle
    De For, Todd E.
    Shune, Leyla
    Cooley, Sarah
    Weisdorf, Daniel J.
    Warlick, Erica D.
    Ustun, Celalettin
    BLOOD, 2012, 120 (21)
  • [36] A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS
    Siyu Gu
    Jingya Xia
    Yulu Tian
    Jie Zi
    Zheng Ge
    BMC Cancer, 21
  • [37] A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS
    Gu, Siyu
    Xia, Jingya
    Tian, Yulu
    Zi, Jie
    Ge, Zheng
    BMC CANCER, 2021, 21 (01)
  • [38] DOES REVISED INTERNATIONAL PROGNOSITIC SCORING SYSTEM (IPSS-R) HAVE ANY IMPACT ON CLINICAL OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS?
    Teo, Z.
    Yiu, R.
    Yueh, L. Ling
    Ho, A.
    HAEMATOLOGICA, 2013, 98 : 312 - 313
  • [39] Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M
    Rigodanza, Luca
    Consagra, Angela
    Alessandro, Sanna
    Cassari, Margherita
    Tofacchi, Elena
    de Pourcq, Sven Jiulien Maria
    Mattiuz, Giorgio
    Amato, Cristina
    Raddi, Marco Gabriele
    Santini, Valeria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S367 - S368
  • [40] Response to Hypomethylating Agents in Myelodysplastic Syndromes Based on WHO 2008 Subtypes and IPSS-R Stratification and Impact on Survival
    Alkhateeb, Hassan B.
    Hreh, Muhanad
    Damlaj, Moussab
    Elliott, Michelle
    Hogan, William J.
    Patnaik, Mrinal M.
    Litzow, Mark R.
    Al-Kali, Aref
    BLOOD, 2015, 126 (23)
12345